Shu-Fang Chen Selected Research

Shu-Fang Chen Research Topics

Disease

4	Epilepsy (Aura) 07/2021 - 01/2018
4	Hydrocephalus (Hydrocephaly) 10/2012 - 09/2005
3	Stroke (Strokes) 09/2020 - 01/2011
3	Status Epilepticus (Complex Partial Status Epilepticus) 09/2020 - 02/2019
3	Infections 01/2014 - 09/2005
3	Meningitis 01/2014 - 09/2005
2	Muscular Diseases (Myopathy) 01/2023 - 03/2014
2	Cerebrotendinous Xanthomatosis 03/2014 - 05/2011
2	Ischemic Stroke 01/2014 - 01/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Chronic Hepatitis B 01/2023
1	Obesity 07/2021
1	Body Weight (Weight, Body) 07/2021
1	Non-alcoholic Fatty Liver Disease 07/2021
1	Vascular Diseases (Vascular Disease) 07/2021
1	Drug Resistant Epilepsy 10/2020
1	Focal Cortical Dysplasia 10/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2020
1	Partial Epilepsies (Epilepsy, Partial) 01/2018
1	Temporal Lobe Epilepsy 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Nasopharyngeal Carcinoma 03/2013
1	Coinfection 10/2012
1	Diabetic Neuropathies (Diabetic Neuropathy) 07/2012
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Craniocerebral Trauma (Head Injury) 05/2011
1	Fever (Fevers) 05/2011
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2011
1	Cerebral Infarction 05/2011
1	Muscle Weakness 03/2011
1	Cerebrospinal Fluid Leak 03/2010
1	Leukocytosis (Pleocytosis) 03/2010
1	Community-Acquired Infections 03/2010
1	Glomerulonephritis 12/2009
1	Proteinuria 12/2009
1	Staphylococcal Infections 09/2007
1	Bacterial Meningitis 09/2007
1	Movement Disorders (Movement Disorder) 03/2006
1	Neurologic Manifestations (Neurological Manifestations) 03/2006
1	Dyskinesias (Dyskinesia) 03/2006
1	Acinetobacter Infections 09/2005

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 07/2021 - 05/2011
2	Adrenergic Agents (Adrenergic Drugs)IBA 04/2021 - 01/2018
2	Neuroprotective AgentsIBA 09/2020 - 02/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2011 - 09/2005
1	Hepatitis B e AntigensIBA 01/2023
1	nasIBA 01/2023
1	Telbivudine FDA Link 01/2023
1	Triglycerides (Triacylglycerol)IBA 07/2021
1	Zonisamide (Zonegran)FDA LinkGeneric 07/2021
1	C-Reactive ProteinIBA 07/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2021
1	HomocysteineIBA 07/2021
1	MicroRNAs (MicroRNA)IBA 10/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2020
1	Mitogen-Activated Protein KinasesIBA 09/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2020
1	Sirtuin 1IBA 07/2019
1	Caspase 3 (Caspase-3)IBA 02/2019
1	ResveratrolIBA 02/2019
1	Insulin-Like PeptidesIBA 01/2018
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Uric Acid (Urate)IBA 01/2016
1	6-chloropenicillanic acid S-sulfoxideIBA 01/2016
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 03/2014
1	Sulfhydryl Compounds (Thiols)IBA 01/2014
1	AntioxidantsIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2014
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2012
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	NAD (NADH)IBA 07/2012
1	Carbon MonoxideIBA 03/2011
1	Erythropoietin FDA Link 01/2011
1	erucylphosphocholineIBA 01/2011
1	beta-Lactamases (beta-Lactamase)IBA 03/2010
1	SaltsIBA 12/2009
1	CoagulaseIBA 09/2007
1	OrganophosphatesIBA 03/2006
1	Carbapenems (Carbapenem Antibiotics)IBA 09/2005
1	Ceftazidime (Fortum)FDA LinkGeneric 09/2005
1	Meropenem (Merrem)FDA LinkGeneric 09/2005

Therapy/Procedure

2	Therapeutics 07/2021 - 01/2011
1	Radiotherapy 03/2013
1	Ventriculoperitoneal Shunt 05/2011
1	Craniotomy 05/2011